APA (7th ed.) Citation

Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), & International Conference on Harmonisation. (2005). Guidance for industry: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research.

Chicago Style (17th ed.) Citation

Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), and International Conference on Harmonisation. Guidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2005.

MLA (9th ed.) Citation

Center for Drug Evaluation and Research (U.S.), et al. Guidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, 2005.